日本語 
Pharma
Hitachi, Ltd. has entered a licensing agreement with Shionogi & Co., Ltd. to roll out a generative AI solution that supports the creation of regulatory documents in drug development. The…
Kura and Kyowa Report Strong KOMZIFTI AML Data
Kura Oncology and Kyowa Kirin rolled out fresh data on KOMZIFTI ziftomenib…
Meiji Seika Pharma Supports Lyric Bio in Ig Manufacturing
Meiji Seika Pharma Co., Ltd. announced a strategic equity investment in Lyric…
Ubie and Kameda Hospital Start AI Obesity Treatment PoC
Ubie Inc. is pleased to announce that, in collaboration with Kameda General…
Eisai Seeks Approval for Subcutaneous LEQEMBI in Japan
Eisai and its global partner Biogen have filed a new drug application…
Kinko’s and Veeva Japan enter into partnership agreement
Veeva Japan Co., Ltd., the Japanese subsidiary of Veeva Systems, a global…
Otsuka Files FDA application for Centanafadine ADHD Drug
Otsuka Pharmaceutical Development & Commercialization, Inc. and Otsuka Pharmaceutical Co., Ltd. announce…
Emulate and FUJIFILM Unveil Brain-Chip R1
Emulate and FUJIFILM Cellular Dynamics have launched the Brain-Chip R1, a new…
BostonGene partners with Kyoto University on AI drug R&D
BostonGene and the University of Kyoto have come together to get more…
English